Agree. I fully expect a news of starting Phase 1 clinical trials with the IDE approval PR, or shortly after. I’m holding through Phase 1. I expect Phase 1 completion before end of year. And given proven results already with pets, I expect same with humans. Boom!!! $RDGL!
100% I’m holding. We know the potential of this stock— have for years. Anyone who sells for under $1.00 will miss out on significantly more upside once they announce phase 1.
News 
Market Data 
Discover 
